INCY

Incyte (INCY) RSI Live Chart

$120.03−0.32% 1DMC $24.47BNeutral

Incyte (INCY) is trading around $120.03. Its daily RSI is 56.65, which is neutral, and its weekly RSI is 56.77 (neutral). The table below shows the live RSI on every timeframe.

Incyte RSI by timeframe

TimeframeRSI (14)Signal
30m55.64Neutral
1h57.74Neutral
1d56.65Neutral
1w56.77Neutral
1mo71.72Overbought

Live, updates every few minutes. RSI period 14.

Incyte at a glance

1 week
+5.96%
1 month
+4.12%
3 months
−0.48%
1 year
+29.61%
52-week high
$132.59
52-week low
$89.28
Market cap
$24.47B#355 in the S&P 500
In the S&P 500 since
2017

Incyte (INCY) is an S&P 500 company in the Health Care sector, classified under Biotechnology and headquartered in Wilmington, Delaware. Founded in 1991, it has been in the index since 2017. By market cap it is the 355th largest company in the S&P 500 and the 46th largest of 60 in Health Care.

Over the past year INCY is up 29.6%, while the S&P 500 (SPY) is up 10.6%. It trades 9.5% below its 52-week high of $132.59 and 34.4% above its 52-week low of $89.28.

What the INCY RSI tells you

The Relative Strength Index (RSI) measures the speed and size of recent price moves on a scale from 0 to 100. It is one of the most widely used momentum indicators in stock trading.

A reading at or below 30 is considered oversold: selling may be overextended and a bounce more likely. A reading at or above 70 is overbought: buying may be stretched and a pullback more likely. Between 30 and 70 is neutral. Signals are strongest when several timeframes agree, which is why the table above shows Incyte on all of them at once.

RSI is a guide, not a guarantee. A stock can stay oversold or overbought for a long time in a strong trend. Traders usually combine it with divergences, volume and structure, all of which you can check on the live chart.

More Health Care stocks

See all stocks